ABT Return on Tangible Equity | ABBOTT LABORATORIES

ABBOTT LABORATORIES (ABT) Return on Tangible Equity

2026-03-31: Return Tang Equity 40.13%.
2025-12-31: Return Tang Equity 24.26%.
2025-09-30: Return Tang Equity 53.57%.
2025-06-30: Return Tang Equity 54.13%.

Complete source-backed return tang equity history.

Available history: 2007-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-03-31	40.13%
2025-12-31	24.26%
2025-09-30	53.57%
2025-06-30	54.13%
2025-03-31	54.73%
2024-12-31	56.38%
2024-09-30	37.59%
2024-06-30	36.53%
2024-03-31	38.46%
2023-12-31	40.48%
2023-09-30	38.60%
2023-06-30	39.41%
2023-03-31	43.72%
2022-12-31	53.00%
2022-09-30	62.69%
2022-06-30	66.69%
2022-03-31	68.36%
2021-12-31	60.68%
2021-09-30	71.06%
2021-06-30	68.06%
2021-03-31	63.76%
2020-12-31	57.33%
2020-09-30	49.39%
2020-06-30	49.40%
2020-03-31	58.76%
2019-12-31	55.92%
2019-09-30	63.66%
2019-06-30	60.86%
2019-03-31	63.70%
2018-12-31	64.52%
2018-09-30	24.02%
2018-06-30	29.56%
2018-03-31	14.12%
2017-12-31	16.02%
2017-09-30	33.56%
2017-06-30	21.41%
2017-03-31	29.42%
2016-12-31	11.19%
2016-09-30	10.83%
2016-06-30	21.63%
2016-03-31	23.21%
2015-12-31	39.65%
2015-09-30	41.51%
2015-06-30	34.81%
2015-03-31	35.34%
2014-12-31	20.16%
2014-09-30	15.46%
2014-06-30	17.44%
2014-03-31	17.83%
2013-12-31	17.01%
2013-09-30	29.21%
2013-06-30	30.08%
2013-03-31	37.18%
2011-06-30	58.91%
2011-03-31	69.02%
2010-12-31	86.52%
2010-09-30	115.32%
2010-06-30	126.71%
2010-03-31	101.29%
2009-12-31	61.56%
2009-09-30	65.29%
2009-06-30	69.80%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	24.26%
2024-12-31	56.38%
2023-12-31	40.48%
2022-12-31	53.00%
2021-12-31	60.68%
2020-12-31	57.33%
2019-12-31	55.92%
2018-12-31	64.52%
2017-12-31	16.02%
2016-12-31	11.19%
2015-12-31	39.65%
2014-12-31	20.17%
2013-12-31	17.02%
2012-12-31	58.14%
2011-12-31	59.69%
2010-12-31	86.52%
2009-12-31	61.56%
2008-12-31	65.14%
2007-12-31	47.14%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
PFIZER INC (PFE)	United States	$162.042B	31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)	United States	$132.481B	28.56
BRISTOL MYERS SQUIBB CO (BMY)	United States	$125.637B	12.67
REGENERON PHARMACEUTICALS, INC. (REGN)	United States	$74.751B	21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)	United States	$33.420B	54.94
Zoetis Inc. (ZTS)	United States	$29.045B	11.38
INSMED Inc (INSM)	United States	$26.566B	-26.60
Roivant Sciences Ltd. (ROIV)		$26.105B	-96.08
Royalty Pharma plc (RPRX)	United States	$22.628B
UNITED THERAPEUTICS Corp (UTHR)	United States	$20.249B	17.64